ImpaQ Ecosystem•Clarivate, Scopus & CORE Data
Clarivate WoS 2024 / 2025 Data
IMPAQ
WoS SCIE Q1Scopus Q1SCImago #14Top JournalHybrid

Annals of Oncology

Acronym:annonc
•
Abbreviation (ISO):ANN ONCOL
•
Identifier (ISSN):0923-7534(Print)/1569-8041(Online)
•
Publisher:Oxford University Press
Clarivate IF (2026)
80.4↑ +15
Journal Impact Factor
IF Trend↓
WoS Quartile
Q1
WoS SCIETop Tier
Clarivate WoS JCR
WoS Categories↓
JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for Annals of Oncology

WoS Q1
9407110313.9201814.2201918.3202033.0202151.8202250.5202356.7202465.4202580.42026
Annual Impact Factor Metric
Current (2026):80.4
Scopus SJR & RankScopus Q1
21.715
#14

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025
H-Index (2025)
331

331 papers with at least that number of citations each

WoS: SCIE / JCRTop Tier
Self-Citation Rate0.9%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessHybrid
125articles/year
38.32% Gold OA•91.21% Original Research

Aims & Scope

Annals of Oncology, the journal of the European Society for Medical Oncology and the Japanese Society of Medical Oncology, provides rapid and efficient peer-review publications on innovative cancer treatments or translational work related to oncology and precision medicine. Main focuses of interest include: systemic anticancer therapy (with specific interest on molecular targeted agents and new immune therapies), randomized trials (including negatives ones), top-level guidelines, and new fields currently emerging as key components of personalized medicine, such as molecular pathology, bioinformatics, modern statistics, and biotechnologies. Radiotherapy, surgery and pediatrics manuscripts can be considered if they display a clear interaction with one of the fields above or are paradigm-shifting.

Topics Covered (Recognized by AI)
Medicine99.9%Internal medicine86.8%Biology86.5%Genetics81%Oncology69.4%Cancer66.9%Pathology51.1%Surgery47.4%Chemistry36.8%Chemotherapy30.9%Biochemistry27.7%Immunology25.7%Cancer research22.4%
Primary Research Areas

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
JCRSCIE2026

ONCOLOGY

Q1
Rank3/333
IndexSCIE
JCISCIE2026

ONCOLOGY

Q1
Rank3/333
IndexSCIE

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
2026Latest
IF80.4
Articles / Year720
Total Citations349
2025
IF65.4
Articles / Year5,417
Total Citations5,003
2024
IF56.7
Articles / Year4,099
Total Citations11,917
2023
IF50.5
Articles / Year4,297
Total Citations18,273
2022
IF51.769
Articles / Year4,163
Total Citations26,858

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #14Scopus Q1SCImago Profile
Scopus Coverage:1990-2026
Scopus Broad Areas:Medicine
Scopus Citation Rank (SJR)Q1
21.715

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q1
Citations / Doc (2 years)
25.93

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$5,489 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations12,368
3-Year Documents471
Citable Documents266

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)5

Citations in government and international policy documents

Female Author Rate39.1%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

HematologyQ1
Medicine (miscellaneous)Q1
OncologyQ1
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 0.9%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
1区 (Zone 1)Medicine
Minor Category (Specific Field):
1区ONCOLOGY
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Annals of Oncology (acronym: annonc, abbr: ANN ONCOL, ISSN: 0923-7534) is a peer-reviewed international scholarly journal in the field of Medicine, published by Oxford University Press in England since 1990. The periodical holds a Journal Impact Factor (JIF) of 80.4, ranking in quartile Q1 of Web of Science (SCIE), a Scopus SJR indicator of 21.7 (Q1), an H-index of 331.

The journal enforces rigorous peer evaluation with a publication frequency of Monthly, an annual output of approximately 125 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $5,489 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Open Access Model
Hybrid
Publisher
Oxford University Press
Publication Language
English
Frequency
Monthly
Founding Year
1990
Indexing & Databases
SCIEScopusPubMed
Editorial Address
OXFORD UNIV PRESS, GREAT CLARENDON ST, OXFORD, ENGLAND, OX2 6DP

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: 7cbb6b75-7821-483f-8e0b-368e364e6dc8
Database Updated: 2026-10-01